Status:
TERMINATED
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
Lead Sponsor:
AstraZeneca
Conditions:
Stable Coronary Artery Disease (CAD), Myocardial Infarction
Eligibility:
All Genders
50+ years
Brief Summary
THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI, including a description of patient characteristics, current treatment patterns, rate of m...
Detailed Description
TIGRIS is a multinational, multi-centre, observational, prospective, longitudinal cohort study which will include stable CAD patients with history of MI 1-3 years ago and high risk of developing ather...
Eligibility Criteria
Inclusion
- \- Stable CAD patients aged 50 years or older with documented history of presumed spontaneous MI with their most recent MI occurring 1 to 3 years prior to enrollment and have at least 1 of the following risk factors: age ≥ 65 years; diabetes mellitus requiring medication; documented history of a second prior presumed spontaneous MI (\>1 year ago); documented history of angiographic evidence of multivessel coronary artery disease; chronic renal dysfunction.
Exclusion
- Presence of serious co-morbidities in the opinion of the investigator which may limit life expectancy (\<1 year)
- Current participation in a blinded randomized clinical trial.
- Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient
- Patients receiving treatment of ticagrelor beyond 12 months, or off label use of ticagrelor.
Key Trial Info
Start Date :
June 19 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2017
Estimated Enrollment :
9284 Patients enrolled
Trial Details
Trial ID
NCT01866904
Start Date
June 19 2013
End Date
March 31 2017
Last Update
September 4 2018
Active Locations (309)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Huntsville, Alabama, United States
2
Research Site
Los Angeles, California, United States
3
Research Site
Santa Ana, California, United States
4
Research Site
Torrance, California, United States